Home | Welcome to Contract Pharma   
Last Updated Sunday, September 21 2014
Print

Breaking News

April 29, 2014
Gains lead preclinical asset for neurodegenerative diseases  Read More »
April 29, 2014
Neubauer and Lopez to drive growth in Germany, the Netherlands and Spain  Read More »
April 29, 2014
Leverages RaveTSDV technology for risk-based monitoring of clinical trial sites  Read More »
April 28, 2014
To use PLX cell therapies in Phase I-III trials  Read More »
April 28, 2014
Fleming brings more than 25 years of biopharma experience  Read More »
April 28, 2014
To develop therapeutic antibodies for cancer treatments  Read More »
April 28, 2014
Expands portfolio of single-use components for biopharma applications  Read More »
April 25, 2014
Offers delivery of clinical trial drugs to a patient's home or a remote clinic  Read More »
April 25, 2014
Gianella-Borradori brings 20 years of R&D experience  Read More »
April 25, 2014
HUMIRA sales drive growth in the quarter  Read More »
April 24, 2014
Solaris revenue up 67% in the quarter  Read More »
April 24, 2014
Cymbalta and Evista patent expirations impact results  Read More »
April 24, 2014
Employs Novozymes' VELTIS technology for optimized dosing  Read More »
April 24, 2014
Phase I trial to employ prediction marker using Evotec's Proteome platform  Read More »
April 24, 2014
Will support cancer drug development programs  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On